
![]()
Genomics Institute of the Novartis Research Foundation
As part of its drug discovery mission, the Genomics Institute of the Novartis Research Foundation (GNF) develops innovative technology that makes possible new approaches to complex biomedical problems in core areas such as Cancer Biology, Infectious Disease, Immunology and Metabolic/Cardiovascular Disease.
Located in San Diego, California, GNF is home to 580 scientists and engineers who work to understand the underlying causes of disease and to design and manufacture unique technologies, such as high-throughput automation systems, that enable breakthrough biology to accelerate the drug discovery process.
GNF maintains strong relationships with academic institutions throughout California, including The Scripps Research Institute, The Salk Institute, UCSD and UCSF, to further enhance its discovery capabilities.
With its unique and synergistic blend of basic science, engineering, and drug discovery research, GNF plays a vital role in NIBR's commitment to push the boundaries of science to change the practice of medicine.
Selected Publications
Aryl Hydrocarbon Receptor Antagonists Promote the Expansion of Human Hematopoietic Stem Cells Boitano AE, Wang J, Romeo R, Bouchez LC, Parker AE, Sutton SE, Walker JR, Flaveny CA, Perdew GH, Denison MS, Schultz PG, Cooke MP. Science (10 September 2010); 329 (5997), 1345-1348.
Imaging of Plasmodium Liver Stages to Drive Next-Generation Antimalarial Drug Discovery Meister S, Plouffe DM, Kuhen KL, Bonamy GM, Wu T, Barnes SW, Bopp SE, Borboa R, Bright AT, Che J, Cohen S, Dharia NV, Gagaring K, Gettayacamin M, Gordon P, Groessl T, Kato N, Lee MC, McNamara CW, Fidock DA, Nagle A, Nam TG, Richmond W, Roland J, Rottmann M, Zhou B, Froissard P, Glynne RJ, Mazier D, Sattabongkot J, Schultz PG, Tuntland T, Walker JR, Zhou Y, Chatterjee A, Diagana TT, Winzeler EA. Science (9 December 2011); 334 (6061), 1372-1377.
Piezo1 and Piezo2 Are Essential Components of Distinct Mechanically Activated Cation ChannelsCoste B, Mathur J, Schmidt M, Earley TJ, Ranade S, Petrus MJ, Dubin AE, Patapoutian A. Science (1 October 2010); 330 (6000), 55-60.
Value of medicines
The cost of a drug must be viewed in terms of value provided to patients.
Fighting neglected diseases

The Novartis Institute for Tropical Diseases (NITD) aims to discover novel treatments and prevention methods for major tropical diseases.



